Sort by
Refine Your Search
-
below 2 tonnes CO2e/tonne of aluminium as a supplied component and eventually to Net Zero carbon. This project is concerned with development of high strength aluminium alloys designed to provide better
-
mechanisms improve performance or lifetime e.g. environmental contamination of solar cells. Analytical Science is a priority area supporting UK Industrial Strategy. The project will develop and characterise a
-
be removed before the deadline. During the Late Ordovician (Hirnantian), extensive ice sheets developed across Gondwana, with their northern limit marked by terminal glacial facies preserved in Morocco
-
an emphasis on reaction development and optimization. Training BioProcess aims to train the next generation of bio-innovators. Our interdisciplinary programmes prepare PhD students and researchers with the real
-
fees will be paid. We expect the stipend to increase each year. The start date is October 2026. This fully funded PhD project will merge the latest tools from experimental directed evolution with
-
) and tuition fees will be paid. This fully funded PhD project will develop a new generation of biocatalysts capable of performing challenging nucleophilic aromatic substitution (SNAr) reactions with
-
the UKRI rate (£20,780 for 2025/26) and tuition fees will be paid. We expect the stipend to increase each year. The start date is October 2026. Therapeutic peptides have been developed to treat a wide range
-
University Belfast, University of Manchester, University of Edinburgh and University of Bristol. BioAID will train the next generation of scientists in Artificial Intelligence and data-driven approaches
-
. Chem. Soc. 2021, 143, 9813), and developing their reactivity (e.g. Nat. Commun. 2020, 11, 337). Nevertheless, there are still many elusive actinide-ligand multiple bonds that would be ground-breaking
-
), aptamers, and DNAzymes.[3] Notable recently also is the use of oligonucleotide sequences (mRNA) in the development of a vaccine for SARS CoV 2. Currently, twenty-two oligonucleotide therapeutics have been